Curcumin para Age-Related Cognitive Decline
B Evidencia Al menos un ensayo aleatorizado lo respalda, con resultados mayoritariamente consistentes.A UCLA 18-month RCT found bioavailable curcumin improved memory test performance and reduced brain amyloid/tau PET signals in non-demented adults. Bioavailability of the formulation is the key factor for effectiveness.
Conclusión
A UCLA 18-month RCT found bioavailable curcumin improved memory test performance and reduced brain amyloid/tau PET signals in non-demented adults. Bioavailability of the formulation is the key factor for effectiveness.
Key Study Findings
Población: aging individuals with cognitive decline
Población: None
Población: None
Población: None
Población: Alzheimer's disease patients
Población: None
Key Statistics
10
Estudios
800
Participantes
Mixed
Calificación
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Dosificaciones de uso común
- general:
- 500-2,000 mg/day of enhanced bioavailability form
- cognitivesupport:
- 90-180 mg/day Theracurmin or equivalent
Límite superior: Well-tolerated up to 8,000 mg/day; 12,000 mg/day short-term
Dosificaciones estudiadas en la investigación
| Dosificación | Duración | Efecto | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d | -- | Mixed | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| 100 mg/kg each | 4 weeks | Positive | -- |
Mejor momento para tomar: With meals containing fat and black pepper (piperine) for absorption
Safety & Side Effects
Efectos secundarios reportados
- ⚠ Gastrointestinal discomfort (nausea, diarrhea)
- ⚠ Headache
- ⚠ Skin rash (rare)
- ⚠ Yellow staining of teeth with powder forms
Interacciones conocidas
- ● Anticoagulants (may increase bleeding risk)
- ● Antidiabetic drugs (may enhance blood sugar lowering)
- ● CYP450 substrates (may affect drug metabolism)
- ● Iron supplements (curcumin may chelate iron)
Ingesta máxima tolerable: Well-tolerated up to 8,000 mg/day; 12,000 mg/day short-term
Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.
Frequently Asked Questions
Does Curcumin help with Age-Related Cognitive Decline?
How much Curcumin should I take for Age-Related Cognitive Decline?
Are there side effects of Curcumin?
How strong is the evidence for Curcumin and Age-Related Cognitive Decline?
Related Evidence
Otros ingredientes para Age-Related Cognitive Decline
Curcumin para otras condiciones
References
- [1] Falguni Goel et al.. 3 Biotech. 2026. Neuropharmacology of synaptic plasticity: pathways to cognitive resilience in healthy aging. doi:10.1007/s13205-025-04673-z PubMed
- [2] Marco Fiore et al.. Molecules. 2025. Brain Neurotrophins and Plant Polyphenols: A Powerful Connection. doi:10.3390/molecules30122657 PubMed
- [3] Büşra Yurt Turer et al.. Nutr Rev. 2025. Relationship of Curcumin with Aging and Alzheimer and Parkinson Disease, the Most Prevalent Age-Related Neurodegenerative Diseases: A Narrative Review. doi:10.1093/nutrit/nuae079 PubMed
- [4] Mahsa Yavari et al.. Nutrients. 2025. Mechanisms Linking Obesity, Insulin Resistance, and Alzheimer's Disease: Effects of Polyphenols and Omega-3 Polyunsaturated Fatty Acids. doi:10.3390/nu17071203 PubMed
- [5] Paola Gualtieri et al.. Nutrients. 2025. Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease. doi:10.3390/nu17050922 PubMed
- [6] Yun-Fei Zhu et al.. Phytomedicine. 2025. Plant-based strategies against aging: Focus on bioactive compounds from medicine-food homology plants. doi:10.1016/j.phymed.2025.157052 PubMed
- [7] Samuel Abiodun Kehinde et al.. Int J Mol Sci. 2025. Curcumin and Dementia: A Systematic Review of Its Effects on Oxidative Stress and Cognitive Outcomes in Animal Models. doi:10.3390/ijms26147026 PubMed
- [8] Nida Rasheed et al.. Exp Gerontol. 2025. Co-administration of coenzyme Q10 and curcumin mitigates cognitive deficits and exerts neuroprotective effects in aluminum chloride-induced Alzheimer's disease in aged … doi:10.1016/j.exger.2024.112659 PubMed
- [9] Hao Jiao et al.. Front Aging Neurosci. 2025. Curcumin and neuroplasticity: epigenetic mechanisms underlying cognitive enhancement in aging and neurodegenerative disorders. doi:10.3389/fnagi.2025.1592280 PubMed
- [10] Wenhui Liu et al.. Ecotoxicol Environ Saf. 2025. Mitochondrial translation impairment-triggered neuroinflammation mediates fluoride-induced cognitive deficits. doi:10.1016/j.ecoenv.2025.119187 PubMed
- [11] Feng Gu et al.. Asia Pac J Clin Nutr. 2025. Effects of plant-derived dietary antioxidants on Alzheimer's disease: Focus on ferroptosis. doi:10.6133/apjcn.202512_34(6).0007 PubMed
- [12] Bridget Martinez et al.. Neural Regen Res. 2025. Amelioration of behavioral and neural deficits in animal models of neurodegenerative disease by nanoformulations of curcumin and quercetin. doi:10.4103/NRR.NRR-D-25-00343 PubMed
- [13] Long Chen et al.. Phytother Res. 2025. Natural Products and Exercise Synergy: Unraveling Molecular Mechanisms to Enhance Brain Function in Alzheimer's Disease. doi:10.1002/ptr.70005 PubMed
- [14] Xueyan Feng et al.. Front Pharmacol. 2025. The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of … doi:10.3389/fphar.2025.1672171 PubMed
- [15] Xiaopeng Li et al.. Neurochem Res. 2025. Targeting Liquid-Liquid Phase Separation and Autophagy in Alzheimer's Disease: Insights into Molecular Mechanisms and Therapeutic Potential. doi:10.1007/s11064-025-04623-4 PubMed
- [16] Bruno S Goncalves et al.. Front Nutr. 2025. Nutritional strategies against dementia in rural populations. doi:10.3389/fnut.2025.1677197 PubMed
- [17] Jemema Agnes Tripena Raj et al.. Brain Res. 2025. RAGE signaling pathway in glioblastoma and cognitive decline: Insights into inflammatory mechanisms and therapeutic implications. doi:10.1016/j.brainres.2025.150026 PubMed
- [18] Yanxia Lu et al.. Nutrients. 2025. Curcumin-Rich Curry Consumption Is Associated with Lower Risk of Cognitive Decline and Incidence of Mild Cognitive Impairment or Dementia: An … doi:10.3390/nu17152488 PubMed
- [19] Prabhash Nath Tripathi et al.. Degener Neurol Neuromuscul Dis. 2024. Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants. doi:10.2147/DNND.S452009 PubMed
- [20] JinJin Pei et al.. Ageing Res Rev. 2024. Curcumin-loaded polymeric nanomaterials as a novel therapeutic strategy for Alzheimer's disease: A comprehensive review. doi:10.1016/j.arr.2024.102393 PubMed
- [21] Yoonsu Kim et al.. Biomed Pharmacother. 2024. Taming neuroinflammation in Alzheimer's disease: The protective role of phytochemicals through the gut-brain axis. doi:10.1016/j.biopha.2024.117277 PubMed
- [22] Faizan Ahmad et al.. Ageing Res Rev. 2024. Evolving therapeutic interventions for the management and treatment of Alzheimer's disease. doi:10.1016/j.arr.2024.102229 PubMed
- [23] Priscila Baltazar Gonçalves et al.. Eur J Med Chem. 2024. Natural products targeting amyloid-β oligomer neurotoxicity in Alzheimer's disease. doi:10.1016/j.ejmech.2024.116684 PubMed
- [24] Bianca Sânziana Daraban et al.. Molecules. 2024. Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems. doi:10.3390/molecules29174056 PubMed
- [25] Meysam Amidfar et al.. CNS Neurol Disord Drug Targets. 2024. Role of BDNF Signaling in the Neuroprotective and Memory-enhancing Effects of Flavonoids in Alzheimer's Disease. doi:10.2174/1871527323666230912090856 PubMed
- [26] Oana M Dumitrascu et al.. Acta Neuropathol Commun. 2024. Retinal peri-arteriolar versus peri-venular amyloidosis, hippocampal atrophy, and cognitive impairment: exploratory trial. doi:10.1186/s40478-024-01810-2 PubMed
- [27] Longmin Fan et al.. Naunyn Schmiedebergs Arch Pharmacol. 2024. Therapeutic potential of curcumin on the cognitive decline in animal models of Alzheimer's disease: a systematic review and meta-analysis. doi:10.1007/s00210-024-02946-7 PubMed
- [28] Erjola Bej et al.. Cells. 2024. Neuronal Cell Rearrangement During Aging: Antioxidant Compounds as a Potential Therapeutic Approach. doi:10.3390/cells13231945 PubMed
- [29] Davide Decandia et al.. Int J Mol Sci. 2023. Dietary Protection against Cognitive Impairment, Neuroinflammation and Oxidative Stress in Alzheimer's Disease Animal Models of Lipopolysaccharide-Induced Inflammation. doi:10.3390/ijms24065921 PubMed
- [30] Emily Knight et al.. Metabolites. 2023. The Role of Dietary Antioxidants and Their Potential Mechanisms in Alzheimer's Disease Treatment. doi:10.3390/metabo13030438 PubMed
- [31] Giuseppe Caruso et al.. Pharmacol Ther. 2022. Polyphenols and neuroprotection: Therapeutic implications for cognitive decline. doi:10.1016/j.pharmthera.2021.108013 PubMed
- [32] Haya Hussain et al.. Molecules. 2022. Attenuation of Scopolamine-Induced Amnesia via Cholinergic Modulation in Mice by Synthetic Curcumin Analogs. doi:10.3390/molecules27082468 PubMed
- [33] Aldo Efrain González-Granillo et al.. J Chem Neuroanat. 2022. Curcumin induces cortico-hippocampal neuronal reshaping and memory improvements in aged mice. doi:10.1016/j.jchemneu.2022.102091 PubMed
- [34] Massimiliano Cuccioloni et al.. Int J Mol Sci. 2022. Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization. doi:10.3390/ijms23158710 PubMed
- [35] Ajay Uprety et al.. Behav Neurosci. 2022. Curcumin improves reversal learning in middle-aged rhesus monkeys. doi:10.1037/bne0000497 PubMed
- [36] Friedrich Leblhuber et al.. Nutrients. 2021. The Immunopathogenesis of Alzheimer's Disease Is Related to the Composition of Gut Microbiota. doi:10.3390/nu13020361 PubMed
- [37] Sylwia Śliwińska et al.. Rocz Panstw Zakl Hig. 2021. The role of nutrition in Alzheimer's disease. doi:10.32394/rpzh.2021.0154 PubMed
- [38] W Yang et al.. J Nutr Health Aging. 2021. Effect of Polyphenols on Cognitive Function: Evidence from Population-Based Studies and Clinical Trials. doi:10.1007/s12603-021-1685-4 PubMed
- [39] I-Chen Tsai et al.. Pharmaceuticals (Basel). 2021. The Effect of Curcumin Differs on Individual Cognitive Domains across Different Patient Populations: A Systematic Review and Meta-Analysis. doi:10.3390/ph14121235 PubMed
- [40] Oana M Dumitrascu et al.. Cells. 2021. Retinal Venular Tortuosity Jointly with Retinal Amyloid Burden Correlates with Verbal Memory Loss: A Pilot Study. doi:10.3390/cells10112926 PubMed
- [41] Alessandra Berry et al.. Nutrients. 2021. Curcuma Longa, the "Golden Spice" to Counteract Neuroinflammaging and Cognitive Decline-What Have We Learned and What Needs to Be Done. doi:10.3390/nu13051519 PubMed
- [42] Umair Shabbir et al.. Int J Mol Sci. 2020. Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The Implication of Nanotechnology. doi:10.3390/ijms22010196 PubMed
- [43] Guangchi Sun et al.. Brain Res Bull. 2020. Curcumin alleviates neuroinflammation, enhances hippocampal neurogenesis, and improves spatial memory after traumatic brain injury. doi:10.1016/j.brainresbull.2020.05.009 PubMed
- [44] Mahitab Farghali et al.. Brain Sci. 2020. Can Brain Health Be Supported by Vitamin D-Based Supplements? A Critical Review. doi:10.3390/brainsci10090660 PubMed
- [45] Stella Gagliardi et al.. Molecules. 2020. Curcumin Formulations and Trials: What's New in Neurological Diseases. doi:10.3390/molecules25225389 PubMed
- [46] Julia C Kuszewski et al.. J Nutr. 2020. Evaluation of Cognitive Performance following Fish-Oil and Curcumin Supplementation in Middle-Aged and Older Adults with Overweight or Obesity. doi:10.1093/jn/nxaa299 PubMed
- [47] Li-Na Zhu et al.. Phytother Res. 2019. Curcumin intervention for cognitive function in different types of people: A systematic review and meta-analysis. doi:10.1002/ptr.6257 PubMed
- [48] P Hemachandra Reddy et al.. J Alzheimers Dis. 2018. Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease. doi:10.3233/JAD-170512 PubMed
- [49] Callum Ross et al.. Int J Nanomedicine. 2018. Liposome delivery systems for the treatment of Alzheimer's disease. doi:10.2147/IJN.S183117 PubMed
- [50] Ligia J Dominguez et al.. Acta Biomed. 2018. Nutritional prevention of cognitive decline and dementia. doi:10.23750/abm.v89i2.7401 PubMed
- [51] Marjana Rahman Sarker et al.. Geroscience. 2018. Efficacy of curcumin for age-associated cognitive decline: a narrative review of preclinical and clinical studies. doi:10.1007/s11357-018-0017-z PubMed
- [52] Arrigo F G Cicero et al.. Pharmacol Res. 2018. Botanicals and phytochemicals active on cognitive decline: The clinical evidence. doi:10.1016/j.phrs.2017.12.029 PubMed
- [53] Julia Christina Kuszewski et al.. Adv Nutr. 2018. Can Curcumin Counteract Cognitive Decline? Clinical Trial Evidence and Rationale for Combining ω-3 Fatty Acids with Curcumin. doi:10.1093/advances/nmx013 PubMed
- [54] Shibu M Poulose et al.. Adv Nutr. 2017. Nutritional Factors Affecting Adult Neurogenesis and Cognitive Function. doi:10.3945/an.117.016261 PubMed
- [55] Melania Maria Serafini et al.. Pharmacol Res. 2017. Curcumin in Alzheimer's disease: Can we think to new strategies and perspectives for this molecule? doi:10.1016/j.phrs.2017.08.004 PubMed
- [56] Fu-Chun Zhao et al.. Med Sci Monit. 2017. Design and Development of a Novel Chalcone Derivative as an Anticholinesterase Inhibitor for Possible Treatment of Dementia. doi:10.12659/msm.901842 PubMed
- [57] Graziamaria Corbi et al.. Front Pharmacol. 2016. Dietary Phytochemicals in Neuroimmunoaging: A New Therapeutic Possibility for Humans? doi:10.3389/fphar.2016.00364 PubMed
- [58] Jessica E Beilharz et al.. Nutrients. 2015. Diet-Induced Cognitive Deficits: The Role of Fat and Sugar, Potential Mechanisms and Nutritional Interventions. doi:10.3390/nu7085307 PubMed
- [59] Christopher Millington et al.. Biomed Res Int. 2014. Chronic neuroinflammation in Alzheimer's disease: new perspectives on animal models and promising candidate drugs. doi:10.1155/2014/309129 PubMed
- [60] William O Ogle et al.. Gerontology. 2013. Potential of treating age-related depression and cognitive decline with nutraceutical approaches: a mini-review. doi:10.1159/000342208 PubMed
- [61] Sally A Frautschy et al.. Mol Neurobiol. 2010. Why pleiotropic interventions are needed for Alzheimer's disease. doi:10.1007/s12035-010-8137-1 PubMed
- [62] Michael Grundman et al.. Proc Nutr Soc. 2002. Antioxidant strategies for Alzheimer's disease. doi:10.1079/PNS2002146 PubMed
Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.